See more : Sungmoon Electronics Co., Ltd. (014915.KS) Income Statement Analysis – Financial Results
Complete financial analysis of Immage Biotherapeutics Corp. (IMMG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Immage Biotherapeutics Corp., a leading company in the Financial – Conglomerates industry within the Financial Services sector.
- Auto Partner SA (APR.WA) Income Statement Analysis – Financial Results
- First Watch Restaurant Group, Inc. (FWRG) Income Statement Analysis – Financial Results
- Protagenic Therapeutics, Inc. (PTIX) Income Statement Analysis – Financial Results
- Petgo Corporation (7140.T) Income Statement Analysis – Financial Results
- Jadwa REIT Al Haramain Fund (4332.SR) Income Statement Analysis – Financial Results
Immage Biotherapeutics Corp. (IMMG)
Industry: Financial - Conglomerates
Sector: Financial Services
About Immage Biotherapeutics Corp.
Immage Biotherapeutics Corp. does not have significant business operations. Previously, it was engaged in developing novel immunotherapy biologics to treat various cancers in the United States. The company was formerly known as Epicure Charcoal, Inc. and changed its name to Immage Biotherapeutics Corp. in June 2015. The company was founded in 2012 and is headquartered in Bethesda, Maryland. Immage Biotherapeutics Corp. is a subsidiary of Coventry International Limited.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.53K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -8.53K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 62.22K | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 55.38 | 46.80 | 18.56 | 12.01 | 7.68 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 98.88 | 11.97 | 0.00 | 0.00 | 0.00 |
| SG&A | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 145.73K | 58.77 | 18.56 | 12.01 | 7.68 |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 207.95K | 58.77 | 18.56 | 12.01 | 7.68 |
| Cost & Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 216.48K | 58.77 | 18.56 | 12.01 | 7.68 |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 167.90K | 228.49K | 236.56K | 206.30K | 171.86K | 8.53K | 0.83 | 18.56 | 12.01 | 7.68 |
| EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -207.95K | -57.93 | -18.56K | -12.01K | 0.00 |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -216.48K | -58.77 | -18.56 | -12.01 | -7.68 |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -216.48K | -58.77 | -18.56 | -12.01 | -7.68 |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -216.48K | -58.77 | -18.56 | -12.01 | -7.68 |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 145.31M | 101.99K | 562.27K | 1.50M | 1.37M |
| Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 145.31M | 101.99K | 561.29K | 1.37M | 1.37M |
Source: https://incomestatements.info
Category: Stock Reports